Efficacy and safety of Kamishoyosan in patients with climacteric symptom associated with depressive state - Efficacy and safety of Kamishoyosan in patients with climacteric symptom associated with depressive state

niversity hospital, Hirosaki University School of Medicine Dept. of Obstetrics & Gynecology0 个研究点目标入组 40 人开始时间: 2010年4月1日最近更新: 2023年10月17日

试验速览

暂无简介。

•1)Patients with Major Depressive Episode according to the DSM-IV diagnostic criteria 2)Patients with a history of psychiatric disease 3)Patients who have undergone oophorectomy within the last 6 months 4)Patients who have taken neurological drugs (antianxiety drugs, sedative hypnotics, antiepileptic drugs, analeptics/psychostimulants, antiparkinson drugs, psychoneurological drugs, autonomic drugs (benzodiazepines, and antidepressants), and/or Kampo medicine within 2 weeks before enrollment 5)Patients who have used estrogens and gestagens within 4 weeks before enrollment 6)Patients with serious complications (e.g., hepatic, renal, cardiac, pulmonary, hematological, or metabolic diseases) 7)Patients with a history of drug allergy 8)Patients who have been treated with any investigational drug or will participate in a clinical trial within 4 weeks before enrollment 9)Patients for whom paroxetine is contraindicated 10)Other patients who are assessed to be inappropriate for study participation by the investigator, or other relevant persons

发起方

niversity hospital, Hirosaki University School of Medicine Dept. of Obstetrics & Gynecology